---
trial_id: 1339
discovery_date: 2022-07-13 05:56:11.616363
date: 2022-07-13 05:56:11.616363
title: "A 52 Week, Multi-center, Randomized, Double-blind Placebo-controlled Study to Assess the Clinical Efficacy and Safety of Ligelizumab (QGE031) in Decreasing the Sensitivity to Peanuts in Patients With Peanut Allergy"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04984876'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
